TY - CHAP M1 - Book, Section TI - Chapter 37. Liver Cirrhosis and Complications A1 - Sease, Julie M. A2 - Sutton, S. Scott PY - 2011 T2 - McGraw-Hill's NAPLEX® Review Guide AB - The term cirrhosis refers to the histological findings of regenerative hepatic nodules surrounded by fibrous bands (collagenous scars) in the liver.1 These abnormal findings are caused by chronic liver injury and can lead to portal hypertension, esophageal varices, ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome, hepatocellular carcinoma, thrombocytopenia, and coagulopathies. While the exact prevalence of cirrhosis worldwide is difficult to determine for a number of reasons, a reasonable estimate is that up to 1% of populations are afflicted with the histological abnormalities that define cirrhosis. In the United States, liver disease is currently ranked 12th among the leading causes of death.2 Alcoholism and hepatitis C are the most common causes of cirrhosis in the western world.1 Other causes include hepatitis B, nonalcoholic steatohepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, hemochromatosis, Wilson disease, and alpha-1-antitrypsin deficiency. Liver injury has been linked to nearly 1000 drugs.3 Examples of common drugs which may cause liver injury include amiodarone, HMG-CoA reductase inhibitors, highly active antiretroviral therapy, ketoconazole, nicotinic acid, acetaminophen, retinol, rifampin, isoniazid, phenytoin, valproic acid, azathioprine, estrogens, and oral contraceptives. Usually, drug-induced liver disease resembles acute hepatitis, cholestatic liver disease or mixed hepatitis/cholestasis, but may also resemble fibrosis and cirrhosis (eg, methotrexate). SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/04/16 UR - accesspharmacy.mhmedical.com/content.aspx?aid=7253284 ER -